• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Cue BioPharma released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 5.524 M, actual EPS USD -0.3277
04:00
Cue BioPharma released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 2.149M (forecast USD 2.29M), actual EPS USD -0.0738 (forecast USD -0.0933)
04:00
Aug15
Cue Biopharma Reports Quarterly Earnings Exceeding Expectations With Share Price Increase
22:56
Aug13
Cue BioPharma released FY2025 Semi-Annual earnings on August 12 (EST) with actual revenue of USD 3.374 M and EPS of USD -0.2443
03:00
Cue BioPharma released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 2.954 M (forecast USD 2 M), actual EPS USD -0.0888 (forecast USD -0.13)
03:00
Jul1
Cue Biopharma Provides Latest Clinical Progress on CUE-101
20:07

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 2.149 M, Net Income -7.448 M, EPS -0.0738

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.954 M, Net Income -8.482 M, EPS -0.0888

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 421 K, Net Income -12.26 M, EPS -0.165

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More